{"id":"placebo-pill","safety":{"commonSideEffects":[{"rate":null,"effect":"Nocebo effect (adverse events due to negative expectation)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo effects arise from complex neurobiological processes including expectation, conditioning, and the activation of endogenous pain-relief and reward systems. The placebo pill itself contains no active pharmaceutical ingredient; its therapeutic benefit depends entirely on the patient's perception and the clinical context in which it is administered. Placebo effects are well-documented in clinical research and can produce measurable improvements in subjective symptoms, particularly pain, nausea, and fatigue.","oneSentence":"A placebo pill produces therapeutic effects through the patient's psychological expectation and belief in treatment, rather than through any active pharmacological mechanism.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:01:22.908Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Research tool for clinical trials and placebo-controlled studies"},{"name":"Demonstration of placebo effect in educational and research settings"}]},"trialDetails":[{"nctId":"NCT04050410","phase":"EARLY_PHASE1","title":"Autonomic Determinants of POTS - Pilot1","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2019-08-27","conditions":"Postural Tachycardia Syndrome","enrollment":48},{"nctId":"NCT06029296","phase":"EARLY_PHASE1","title":"Diclofenac as a KMO Inhibitor","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2024-07-31","conditions":"Alcohol Use Disorder","enrollment":12},{"nctId":"NCT04140721","phase":"EARLY_PHASE1","title":"Autonomic Determinants of POTS - Pilot 2","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2021-08-31","conditions":"Postural Tachycardia Syndrome","enrollment":48},{"nctId":"NCT06063486","phase":"PHASE2","title":"Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms","status":"RECRUITING","sponsor":"University of Southern California","startDate":"2024-03-01","conditions":"Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome","enrollment":30},{"nctId":"NCT04599478","phase":"PHASE2, PHASE3","title":"Pharmacological and Behavioral Treatment After Bariatric Surgery: Acute (Stage 1)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yale University","startDate":"2021-06-29","conditions":"Loss-of-control Eating, Obesity/Overweight","enrollment":160},{"nctId":"NCT05538910","phase":"NA","title":"Defining Neurobiological Links Between Substance Use and Mental Illness","status":"RECRUITING","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2023-02-02","conditions":"Major Depressive Disorder, Substance Use Disorder, Normal Physiology","enrollment":620},{"nctId":"NCT04734080","phase":"PHASE4","title":"Dronabinol in Total Knee Arthroplasty (TKA)","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2021-03-09","conditions":"Total Knee Arthroplasty, Opioid Use","enrollment":114},{"nctId":"NCT06610968","phase":"NA","title":"Acute Vitamin D Supplementation on Testosterone in Females","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Southern California","startDate":"2025-07-01","conditions":"Female Hormone Profile","enrollment":20},{"nctId":"NCT03941808","phase":"NA","title":"Gastroprotected Superoxide Dismutase in Combination With UVB vs Placebo and UVB for Treating Vitiligo.","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2019-06-17","conditions":"Vitiligo","enrollment":50},{"nctId":"NCT03804229","phase":"PHASE3","title":"Efficacy and Safety of Butylphthalide Soft Capsule for the Treatment of Vascular Dementia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Capital Medical University","startDate":"2019-10-29","conditions":"Vascular Dementia","enrollment":707},{"nctId":"NCT05815602","phase":"PHASE3","title":"Ebastine Versus Mebeverine in IBS Patients","status":"RECRUITING","sponsor":"Guy Boeckxstaens","startDate":"2023-03-30","conditions":"IBS - Irritable Bowel Syndrome, IBS","enrollment":200},{"nctId":"NCT05850091","phase":"PHASE4","title":"Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2023-12-07","conditions":"Coronary Artery Disease","enrollment":200},{"nctId":"NCT03668041","phase":"PHASE3","title":"National Adaptive Trial for PTSD Related Insomnia","status":"ACTIVE_NOT_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2021-02-25","conditions":"Insomnia","enrollment":673},{"nctId":"NCT05702398","phase":"EARLY_PHASE1","title":"Pilot Trial of Supplemental Vitamin A and Nicotinamide","status":"RECRUITING","sponsor":"Rhode Island Hospital","startDate":"2023-04-01","conditions":"Skin Cancer, Kidney Transplant Recipients","enrollment":30},{"nctId":"NCT04944836","phase":"PHASE2","title":"Sex Hormone Supplementation and Rotator Cuff Repair: A Preliminary Randomized Trial","status":"RECRUITING","sponsor":"University of Utah","startDate":"2023-03-09","conditions":"Rotator Cuff Tears","enrollment":58},{"nctId":"NCT03844412","phase":"PHASE2","title":"Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments","status":"COMPLETED","sponsor":"Duke University","startDate":"2019-11-04","conditions":"Vestibulodynia, Temporomandibular Disorder, Fibromyalgia Syndrome","enrollment":209},{"nctId":"NCT06164665","phase":"PHASE4","title":"Effects of Pioglitazone on Exogenous Carbohydrate Oxidation During Steady-State Exercise at High Altitude","status":"COMPLETED","sponsor":"United States Army Research Institute of Environmental Medicine","startDate":"2023-03-01","conditions":"High Altitude","enrollment":9},{"nctId":"NCT06807866","phase":"PHASE4","title":"Duloxetine for Perioperative Pain in Hip Arthroplasty: A RCT","status":"RECRUITING","sponsor":"University of Miami","startDate":"2025-03-01","conditions":"THA","enrollment":64},{"nctId":"NCT06093477","phase":"NA","title":"Studying Melatonin and Recovery in Teens","status":"RECRUITING","sponsor":"Stanford University","startDate":"2024-05-30","conditions":"Juvenile; Scoliosis, Scoliosis Idiopathic, Scoliosis; Adolescence","enrollment":45},{"nctId":"NCT02064673","phase":"PHASE3","title":"Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy","status":"RECRUITING","sponsor":"yair lotan","startDate":"2014-05","conditions":"Prostate Cancer","enrollment":608},{"nctId":"NCT06582888","phase":"EARLY_PHASE1","title":"Advancing VR-based Attentional Bias as a Biomarker for Tobacco Use Disorder","status":"RECRUITING","sponsor":"University of California, San Diego","startDate":"2024-11-19","conditions":"Nicotine Addiction, Craving","enrollment":200},{"nctId":"NCT07061574","phase":"PHASE1, PHASE2","title":"A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2026-03-30","conditions":"Type 1 Diabetes, New Onset","enrollment":120},{"nctId":"NCT04791579","phase":"PHASE2","title":"Antibiotic Prophylaxis for Neurogenic Bladder Botox","status":"RECRUITING","sponsor":"University of Alberta","startDate":"2025-02-01","conditions":"Neurogenic Bladder, Post-operative Urinary Tract Infections","enrollment":160},{"nctId":"NCT05886816","phase":"PHASE2","title":"Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2024-03-01","conditions":"SARS-CoV Infection, COVID-19","enrollment":112},{"nctId":"NCT04497168","phase":"PHASE2","title":"Citalopram as a Posterior Cortical Protective Therapy in Parkinson Disease","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2021-04-01","conditions":"Parkinson Disease","enrollment":58},{"nctId":"NCT07466732","phase":"EARLY_PHASE1","title":"Effects of Caffeine Ingestion on Morning Cognitive and Muscle Repeated Sprint Performance in Males","status":"ENROLLING_BY_INVITATION","sponsor":"Liverpool John Moores University","startDate":"2025-12-08","conditions":"Caffeine, Placebo - Control, No Pill","enrollment":15},{"nctId":"NCT07373210","phase":"NA","title":"Open-label Placebo for Pain Management in Adolescents and Young Adults Undergoing Bernese Periacetabular Osteotomy","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2026-03","conditions":"Periacetabular Osteotomy, Opiates","enrollment":64},{"nctId":"NCT07469852","phase":"PHASE1, PHASE2","title":"Effects of Caffeine Ingestion on Morning Cognitive and 4-km Time Trial Performance in Males","status":"ACTIVE_NOT_RECRUITING","sponsor":"Liverpool John Moores University","startDate":"2026-01-12","conditions":"Caffeine, Placebo - Control, No Pill","enrollment":15},{"nctId":"NCT06365892","phase":"NA","title":"Open-label Placebo (COLP) for Pain in Adolescent Idiopathic Scoliosis (AIS) Surgery+Surgical Treatment of Idiopathic Scoliosis","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2024-07-01","conditions":"Adolescent Idiopathic Scoliosis (AIS)","enrollment":64},{"nctId":"NCT07466628","phase":"PHASE4","title":"Effects of Caffeine Ingestion on Morning Cognitive and Muscle Strength Measures in Males","status":"COMPLETED","sponsor":"Liverpool John Moores University","startDate":"2024-11-15","conditions":"Caffine, Placebo - Control, No Pill","enrollment":15},{"nctId":"NCT04916327","phase":"NA","title":"Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 1","status":"RECRUITING","sponsor":"Virginia Commonwealth University","startDate":"2021-08-23","conditions":"Peripheral Vascular Diseases","enrollment":720},{"nctId":"NCT06579209","phase":"NA","title":"NAD+ Oral Supplement Pilot Intervention in Adult Females","status":"COMPLETED","sponsor":"University of Rhode Island","startDate":"2024-12-01","conditions":"Cognitive Change, Inflammation, Neurodegenerative Diseases","enrollment":53},{"nctId":"NCT01351753","phase":"PHASE2","title":"Drug Therapy Induced Weight Loss to Improve Blood Vessel Function in Subjects With Obesity","status":"TERMINATED","sponsor":"University of Iowa","startDate":"2011-03","conditions":"Obesity, Metabolic Syndrome X","enrollment":128},{"nctId":"NCT04769206","phase":"PHASE1, PHASE2","title":"Enhancing Parasympathetic Activity to Improve Endothelial Dysfunction, Vascular Oxidative Stress in African Americans","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2021-12-20","conditions":"Endothelial Dysfunction","enrollment":46},{"nctId":"NCT05359653","phase":"PHASE1, PHASE2","title":"Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2023-08-01","conditions":"Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive","enrollment":74},{"nctId":"NCT06720909","phase":"NA","title":"Mindfulness And Placebo for Pain (MAPP) Study","status":"RECRUITING","sponsor":"Arizona State University","startDate":"2025-01-27","conditions":"Chronic Pain","enrollment":45},{"nctId":"NCT05145452","phase":"NA","title":"n-3 Polyunsaturated Fatty Acids to Prevent and Treat Diabetic Neuropathy","status":"TERMINATED","sponsor":"University of Missouri-Columbia","startDate":"2021-01-14","conditions":"Diabetic Neuropathies","enrollment":31},{"nctId":"NCT06065670","phase":"PHASE1, PHASE2","title":"Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a Myelin Repair Therapy","status":"NOT_YET_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2026-09-15","conditions":"Demyelinating Diseases, Demyelination; Corpus Callosum, Multiple Sclerosis Brain Lesion","enrollment":44},{"nctId":"NCT05901571","phase":"NA","title":"Acupuncture and Escitalopram for Treating Major Depression Clinical Study","status":"NOT_YET_RECRUITING","sponsor":"Shanghai 7th People's Hospital","startDate":"2026-11","conditions":"Depressive Disorder, Major","enrollment":216},{"nctId":"NCT05624528","phase":"PHASE2","title":"A Clinical Trial of Tolcapone in Obsessive Compulsive Disorder","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Chicago","startDate":"2023-06-22","conditions":"Obsessive-Compulsive Disorder, OCD","enrollment":49},{"nctId":"NCT04872660","phase":"PHASE4","title":"Efficacy and Safety of Gushen Antai Pill on Ongoing Pregnancy Rate in Women With Normal Ovarian Reserve Undergoing IVF-ET","status":"RECRUITING","sponsor":"Shandong University of Traditional Chinese Medicine","startDate":"2021-06-15","conditions":"Infertility, Female","enrollment":800},{"nctId":"NCT06408519","phase":"NA","title":"Open-Label Placebo for Non-Specific Pain in the ED","status":"COMPLETED","sponsor":"Bruno Minotti","startDate":"2024-05-23","conditions":"Pain, Acute","enrollment":57},{"nctId":"NCT06973109","phase":"PHASE2","title":"Romosozumab Effects on Bone Density, Muscle Mass, and Spine Surgery Outcomes","status":"NOT_YET_RECRUITING","sponsor":"Nitin Agarwal","startDate":"2026-03-20","conditions":"Osteoporosis, Post-menopausal","enrollment":36},{"nctId":"NCT05362292","phase":"PHASE4","title":"TReating Incontinence for Underlying Mental and Physical Health","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2022-10-04","conditions":"Urinary Incontinence, Urge, Urinary Incontinence, Overactive Bladder","enrollment":270},{"nctId":"NCT03586284","phase":"PHASE2, PHASE3","title":"Systemic and Topical Antivirals for Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2020-03-15","conditions":"Cytomegalovirus Anterior Uveitis","enrollment":51},{"nctId":"NCT05061368","phase":"PHASE2","title":"Oral Sildenafil for Exercise Capacity, Dyspnea and Cardiopulmonary Function in COPD","status":"RECRUITING","sponsor":"University of Alberta","startDate":"2022-03-01","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":160},{"nctId":"NCT05726292","phase":"PHASE2","title":"A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2025-01-06","conditions":"Prostate Cancer, Prostate Adenocarcinoma","enrollment":90},{"nctId":"NCT05350215","phase":"PHASE1, PHASE2","title":"Atomoxetine and DAW2022 on OSA Severity","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2022-06-01","conditions":"Obstructive Sleep Apnea","enrollment":18},{"nctId":"NCT06556277","phase":"NA","title":"Acute Consequences of Glucocorticoid Secretion in Overweight and Obese Individuals During Maximum Calorie Intake","status":"COMPLETED","sponsor":"Eleonora Seelig","startDate":"2024-09-01","conditions":"Glucocorticoids, Overweight and Obesity, Overeating","enrollment":23},{"nctId":"NCT05903859","phase":"PHASE3","title":"Improvement of Reproductive Function in Men With Spinal Cord Injury (SCI)","status":"RECRUITING","sponsor":"University of Miami","startDate":"2024-01-18","conditions":"Infertility, Male","enrollment":90},{"nctId":"NCT07439601","phase":"NA","title":"Long-Term Omega-3 and Omega-3 Index >8%: Effects on Physiological Recovery","status":"NOT_YET_RECRUITING","sponsor":"St. Mary's University, Twickenham","startDate":"2026-02-28","conditions":"Focus on Omega 3 Index on Recovery","enrollment":46},{"nctId":"NCT07298993","phase":"PHASE4","title":"Deprescribing Beta-Blockers in Elders With Heart Failure With Preserved Ejection Fraction (DEPRESCRIBE-HFpEF)","status":"ENROLLING_BY_INVITATION","sponsor":"Weill Medical College of Cornell University","startDate":"2026-02-02","conditions":"Heart Failure, HFpEF, HFpEF - Heart Failure With Preserved Ejection Fraction","enrollment":240},{"nctId":"NCT03598309","phase":"PHASE2","title":"Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers","status":"ACTIVE_NOT_RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2019-06-05","conditions":"Lung Diseases, Lung Cancer, Protection Against","enrollment":19},{"nctId":"NCT07232069","phase":"PHASE3","title":"PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis","status":"NOT_YET_RECRUITING","sponsor":"Duke University","startDate":"2026-07-01","conditions":"Coronary Artery Disease Risk Factors Multiple, Coronary Artery Disease Progression, Prevention & Control","enrollment":1500},{"nctId":"NCT05729243","phase":"PHASE4","title":"Cytisine for Smoking Cessation","status":"COMPLETED","sponsor":"Centre for Addiction and Mental Health","startDate":"2023-02-08","conditions":"Tobacco Use Disorder, Alcohol Use Disorder, Smoking Cessation","enrollment":20},{"nctId":"NCT05855746","phase":"PHASE3","title":"Colchicine Versus Placebo in Acute Myocarditis Patients","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-07-16","conditions":"Acute Myocarditis","enrollment":300},{"nctId":"NCT03553875","phase":"PHASE3","title":"Memantine for the Treatment of Social Deficits in Youth With Disorders of Impaired Social Interactions","status":"TERMINATED","sponsor":"Massachusetts General Hospital","startDate":"2018-11-13","conditions":"Autism, Autism Spectrum Disorder, Nonverbal Learning Disability","enrollment":25},{"nctId":"NCT07433452","phase":"PHASE1","title":"The Effects of Psilocybin in Healthy Volunteers: Psychological, Biochemical and Electrophysiological Biomarkers.","status":"NOT_YET_RECRUITING","sponsor":"Gabriella Gobbi","startDate":"2026-09-01","conditions":"Healthy Participants, Placebo - Control, Psilocybin","enrollment":50},{"nctId":"NCT06882772","phase":"PHASE1, PHASE2","title":"Butyric Acid Supplementation for Gut Improvement After Cardiac Surgery in Kids","status":"NOT_YET_RECRUITING","sponsor":"University of Nebraska","startDate":"2026-03","conditions":"Congenital Heart Disease (CHD)","enrollment":105},{"nctId":"NCT05513560","phase":"PHASE2, PHASE3","title":"RECLAIM: Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine","status":"COMPLETED","sponsor":"University Health Network, Toronto","startDate":"2023-05-31","conditions":"Long COVID, Post COVID Condition, Post Acute Sequelae of COVID-19","enrollment":460},{"nctId":"NCT07098975","phase":"PHASE2","title":"Statin Intervention for Severe Early-Onset Placental Insufficiency. (STATIN-PRE Trial)","status":"RECRUITING","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2026-01-14","conditions":"Preeclampsia (PE), Intrauterine Growth Restriction (IUGR), Placental Insufficiency","enrollment":154},{"nctId":"NCT05356013","phase":"PHASE2","title":"Caplyta in Borderline Personality Disorder","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2023-05-10","conditions":"Borderline Personality Disorder","enrollment":60},{"nctId":"NCT01410942","phase":"PHASE2","title":"Multimodal Therapy for the Treatment of Fatigue in Patients With Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2012-02-08","conditions":"Prostate Cancer","enrollment":175},{"nctId":"NCT07419594","phase":"NA","title":"Estradiol and Intrusive Memories","status":"RECRUITING","sponsor":"Charite University, Berlin, Germany","startDate":"2024-08-19","conditions":"PTSD, Intrusive Memories, Intrusion Symptom","enrollment":273},{"nctId":"NCT07281014","phase":"PHASE4","title":"Unmitigated Aldosterone Signaling During Standard Clinical MRA Dosing","status":"RECRUITING","sponsor":"Yale University","startDate":"2026-01-27","conditions":"Heart Failure","enrollment":20},{"nctId":"NCT05705427","phase":"PHASE4","title":"The COMBAT HBV Feasibility Trial","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2023-08-17","conditions":"Hepatitis B, Vertical Transmission of Infectious Disease","enrollment":317},{"nctId":"NCT07377136","phase":"NA","title":"Influence of the Urolithin A on the Population With BMI Higher Than 30 During Restricted Eating.","status":"ENROLLING_BY_INVITATION","sponsor":"Charles University, Czech Republic","startDate":"2025-10-08","conditions":"Obesity & Overweight","enrollment":100},{"nctId":"NCT06852365","phase":"PHASE2","title":"Combined Oral Contraceptive Pill and Resistance Starch","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2025-06-10","conditions":"Metabolic Syndrome, Polycystic Ovary Syndrome","enrollment":100},{"nctId":"NCT03789760","phase":"PHASE3","title":"The Clinical Trial of Chinese Herbal Medicine (SaiLuoTong) Capsule","status":"COMPLETED","sponsor":"Shineway Pharmaceutical Co.,Ltd","startDate":"2019-04-10","conditions":"Vascular Dementia","enrollment":493},{"nctId":"NCT03229889","phase":"PHASE4","title":"Trial of Tadalafil, Tamsulosin and Combination for Access Sheath Deployment","status":"COMPLETED","sponsor":"University of California, Irvine","startDate":"2017-06-07","conditions":"Nephrolithiasis","enrollment":220},{"nctId":"NCT06957808","phase":"NA","title":"Investigating the Effect of Diroximel Fumarate on Glutathione in Schizophrenia","status":"RECRUITING","sponsor":"King's College London","startDate":"2025-01-10","conditions":"Schizophrenia Disorders","enrollment":30},{"nctId":"NCT07146451","phase":"","title":"6-year Outcomes in Children After Nifedipine vs Placebo for Preterm Prelabor Rupture of Membranes at 22-33 Weeks","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-10-28","conditions":"Children Born to Mothers Enrolled in the TOCOPROM Trial","enrollment":480},{"nctId":"NCT07144826","phase":"EARLY_PHASE1","title":"Effects of a Probiotic Intervention on the Gut and Vaginal Microbiome in Patients With Advanced or Recurrent Ovarian Cancer Undergoing Treatment With Platinum Chemotherapy","status":"RECRUITING","sponsor":"Ohio State University Comprehensive Cancer Center","startDate":"2026-03-09","conditions":"Advanced Ovarian Carcinoma, Recurrent Ovarian Carcinoma, Stage II Ovarian Cancer AJCC v8","enrollment":161},{"nctId":"NCT04276259","phase":"PHASE4","title":"Rapid Antidepressant Improvement Secondary to Excitatory Brain Responses","status":"COMPLETED","sponsor":"Marta Peciña, MD PhD","startDate":"2020-10-19","conditions":"Major Depressive Disorder, Depression","enrollment":120},{"nctId":"NCT06573970","phase":"PHASE4","title":"Atomoxetine and Executive Function in PTSD","status":"NOT_YET_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2026-04-01","conditions":"Posttraumatic Stress Disorder With Attention Defic","enrollment":160},{"nctId":"NCT06438861","phase":"NA","title":"Role of Combination Therapy in Women With Refractory Overactive Bladder","status":"WITHDRAWN","sponsor":"University of Alabama at Birmingham","startDate":"2025-01-01","conditions":"Overactive Bladder Syndrome","enrollment":""},{"nctId":"NCT06608433","phase":"NA","title":"Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Function","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2025-01-16","conditions":"Healthy Volunteer Study, HPA, Cortisol Deficiency","enrollment":22},{"nctId":"NCT07398508","phase":"PHASE1, PHASE2","title":"Phase I/II Study of NORTHERA (DROXIDOPA) for Dysautonomia in Pediatric Survivors of Menkes Disease.","status":"RECRUITING","sponsor":"Stephen G. Kaler","startDate":"2026-06-01","conditions":"Menkes Disease","enrollment":6},{"nctId":"NCT04183205","phase":"PHASE4","title":"Predicting SSRI Efficacy in Veterans With PTSD","status":"TERMINATED","sponsor":"VA Office of Research and Development","startDate":"2019-09-11","conditions":"Posttraumatic Stress Disorder, Major Depressive Disorder","enrollment":26},{"nctId":"NCT06063200","phase":"EARLY_PHASE1","title":"Methylphenidate and Response to Alcohol Cues Pilot Study","status":"COMPLETED","sponsor":"University of Florida","startDate":"2024-03-20","conditions":"Alcohol Use Disorder, Attention Deficit Hyperactivity Disorder","enrollment":31},{"nctId":"NCT02162849","phase":"PHASE4","title":"Reward Sensitivity and Pharmacotherapy for Smoking Cessation","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2015-12-14","conditions":"Tobacco Use Cessation","enrollment":204},{"nctId":"NCT07323524","phase":"PHASE4","title":"Dapagliflozin in Active Lupus Nephritis","status":"NOT_YET_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2026-02-01","conditions":"Lupus Nephritis (LN)","enrollment":33},{"nctId":"NCT04850846","phase":"PHASE2","title":"Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2021-04-27","conditions":"Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma","enrollment":60},{"nctId":"NCT04383262","phase":"PHASE2","title":"Fosamprenavir for Laryngopharyngeal Upper Airway Tissue Treatment and Enzyme Reduction","status":"NOT_YET_RECRUITING","sponsor":"Medical College of Wisconsin","startDate":"2026-04-01","conditions":"Laryngopharyngeal Reflux","enrollment":104},{"nctId":"NCT07396857","phase":"NA","title":"The Role of EDHFs on Blood Pressure Following a Bout of Prolonged Sitting","status":"RECRUITING","sponsor":"Université de Sherbrooke","startDate":"2025-11-01","conditions":"Cardiovascular","enrollment":40},{"nctId":"NCT07111988","phase":"PHASE2","title":"Valbenazine in Obsessive Compulsive Disorder","status":"NOT_YET_RECRUITING","sponsor":"University of Chicago","startDate":"2026-02","conditions":"Obsessive-Compulsive Disorder","enrollment":30},{"nctId":"NCT02655315","phase":"PHASE2","title":"Conservative Iron Chelation as a Disease-modifying Strategy in Parkinson's Disease","status":"COMPLETED","sponsor":"University Hospital, Lille","startDate":"2016-02-09","conditions":"Parkinson Disease","enrollment":372},{"nctId":"NCT04594746","phase":"PHASE4","title":"Oral Amiodarone for Acute Cardioversion of Atrial Fibrillation Study","status":"TERMINATED","sponsor":"University of Calgary","startDate":"2022-02-03","conditions":"Atrial Fibrillation","enrollment":3},{"nctId":"NCT06281665","phase":"PHASE4","title":"Treatment With Aspirin After Preeclampsia: TAP Trial","status":"RECRUITING","sponsor":"Malamo Countouris","startDate":"2024-05-29","conditions":"Hypertensive Disorder of Pregnancy, Pre-Eclampsia, Hypertension","enrollment":60},{"nctId":"NCT02595346","phase":"PHASE2","title":"Study of the Efficiency of Hydroxychloroquine on the Endothelial Dysfunction and Its Vascular Consequences During the Antiphospholipid Syndrome","status":"COMPLETED","sponsor":"University Hospital, Rouen","startDate":"2016-05-17","conditions":"Antiphospholipid Syndrome (APS)","enrollment":25},{"nctId":"NCT05421416","phase":"PHASE2","title":"Loratadine for the Prevention of G-CSF-related Bone Pain","status":"RECRUITING","sponsor":"AHS Cancer Control Alberta","startDate":"2024-11-28","conditions":"Stem Cell Transplant Complications","enrollment":78},{"nctId":"NCT05212298","phase":"NA","title":"Effects of Herbal Sleep Formula on Patients With Insomnia and Tinnitus","status":"COMPLETED","sponsor":"Dalin Tzu Chi General Hospital","startDate":"2021-09-16","conditions":"Sleep Disturbances, Tinnitus","enrollment":108},{"nctId":"NCT04860141","phase":"PHASE4","title":"Efficacy of Preoperative Administration of Gabapentin in 3rd Molar Dental Extraction.","status":"RECRUITING","sponsor":"Loma Linda University","startDate":"2021-06-16","conditions":"Dental Pain and Sensation Disorder, Pain, Postoperative","enrollment":98},{"nctId":"NCT04599504","phase":"PHASE2, PHASE3","title":"Pharmacological and Behavioral Treatment After Bariatric Surgery: Medication Change for Non-Responders (Stage 2b)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yale University","startDate":"2022-01-02","conditions":"Loss-of-control Eating, Obesity/Overweight","enrollment":60},{"nctId":"NCT06377072","phase":"PHASE3","title":"Efficacy and Safety of Shenqi Sherong Pill in Participants With Cervical Spondylotic Myelopathy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Shanghai Hutchison Pharmaceuticals Limited","startDate":"2024-05-11","conditions":"Cervical Spondylotic Myelopathy","enrollment":428},{"nctId":"NCT06222268","phase":"PHASE1","title":"Wayne State Warriors Marijuana Clinical Research Program: Cannabinoid Adjunct to Prolonged Exposure & Recovery","status":"NOT_YET_RECRUITING","sponsor":"Wayne State University","startDate":"2026-03","conditions":"PTSD, Post Traumatic Stress Disorder","enrollment":280},{"nctId":"NCT07223580","phase":"PHASE4","title":"A Study Of Corticosteroid On Postoperative Pain After Ureteroscopy For Urinary Calculi","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2026-01-23","conditions":"Ureteroscopy, Post Operative Pain","enrollment":90},{"nctId":"NCT04666636","phase":"PHASE2","title":"Mechanisms for Activation of Beige Adipose Tissue in Humans","status":"RECRUITING","sponsor":"Philip Kern","startDate":"2020-12-07","conditions":"PreDiabetes","enrollment":65},{"nctId":"NCT05147090","phase":"PHASE4","title":"Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"The University of Hong Kong","startDate":"2022-01-02","conditions":"Chronic Hepatitis b, NAFLD, Cirrhosis","enrollment":106},{"nctId":"NCT03944629","phase":"","title":"Efficacy of Arnica Montana in Reducing Postoperative Edema and Pain","status":"COMPLETED","sponsor":"Tufts University","startDate":"2018-01-26","conditions":"Arnica, Third Molar Extraction","enrollment":53}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":200,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["soybean oil placebo capsules","inactive substance","Placebo Oral Pill","methylcellulose (sugar pill)","sugar pill"],"phase":"marketed","status":"active","brandName":"Placebo pill","genericName":"Placebo pill","companyName":"National Institute on Drug Abuse (NIDA)","companyId":"national-institute-on-drug-abuse-nida","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A placebo pill produces therapeutic effects through the patient's psychological expectation and belief in treatment, rather than through any active pharmacological mechanism. Used for Research tool for clinical trials and placebo-controlled studies, Demonstration of placebo effect in educational and research settings.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":11,"withResults":4},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}